Not applicableEnded earlyNCT00724061What this trial is testingStudy of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCLWho this might be right forLymphoma Northwestern University 7
Early research (Phase 1)Ended earlyNCT01738594What this trial is testingDose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell LymphomaWho this might be right forRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+11 more Northwestern University 7
Early research (Phase 1)Study completedNCT04702503What this trial is testingStudy of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)Who this might be right forCutaneous T-Cell Lymphoma/Mycosis Fungoides Moleculin Biotech, Inc. 5
Not applicableStudy completedNCT00066664What this trial is testingSerum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal SkinWho this might be right forLymphoma National Institutes of Health Clinical Center (CC) 423
Testing effectiveness (Phase 2)Study completedNCT00406809What this trial is testingABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesWho this might be right forChronic Lymphoid LeukemiaLymphoid MalignanciesNon-Hodgkin's Lymphoma+3 more AbbVie (prior sponsor, Abbott) 81
Large-scale testing (Phase 3)Study completedNCT02448381What this trial is testingFLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)Who this might be right forCutaneous T-Cell Lymphoma Soligenix 169
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT04848064What this trial is testingThird-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/LymphomaWho this might be right forRecurrent Adult T-Cell Leukemia/LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Adult T-Cell Leukemia/Lymphoma+1 more John Reneau 12
Early research (Phase 1)Study completedNCT00002687What this trial is testingInterleukin-2 in Treating Patients With Mycosis FungoidesWho this might be right forLymphoma University of Washington 30
Not applicableStudy completedNCT06113081What this trial is testingReal World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell LymphomaWho this might be right forCutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome Fondazione Italiana Linfomi - ETS 100
Early research (Phase 1)UnknownNCT03775525What this trial is testingStudy Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerWho this might be right forAdvanced CancerGastric CancerBreast Cancer+14 more Genzada Pharmaceuticals USA, Inc. 127
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Ended earlyNCT00490776What this trial is testingStudy of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)Who this might be right forCutaneous T-Cell Lymphoma Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01352520What this trial is testingSGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)Who this might be right forCD-30 Positive Anaplastic Large T-cell Cutaneous LymphomaLymphoma, Primary Cutaneous Anaplastic Large CellLymphomatoid Papulosis+5 more M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)Study completedNCT00061880What this trial is testingBCX-1777 in Treating Patients With Refractory Cutaneous T-Cell LymphomaWho this might be right forLymphoma BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00823524What this trial is testingDonor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Asan Medical Center 47
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04930653What this trial is testingExtracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell LymphomaWho this might be right forFolliculotropic Mycosis FungoidesPrimary Cutaneous T-Cell Non-Hodgkin LymphomaSezary Syndrome+5 more City of Hope Medical Center 34
Large-scale testing (Phase 3)Study completedNCT00006083What this trial is testingDalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterWho this might be right forCervical CancerChronic Myeloproliferative DisordersLeukemia+6 more Jonsson Comprehensive Cancer Center